Compare DERM & TPVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DERM | TPVG |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.3M | 224.9M |
| IPO Year | 2021 | 2013 |
| Metric | DERM | TPVG |
|---|---|---|
| Price | $7.45 | $5.39 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 5 |
| Target Price | ★ $12.67 | $5.90 |
| AVG Volume (30 Days) | ★ 209.9K | 190.3K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 17.66% |
| EPS Growth | ★ 34.72 | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $61,858,000.00 | N/A |
| Revenue This Year | $39.72 | $7.67 |
| Revenue Next Year | $63.24 | N/A |
| P/E Ratio | ★ N/A | $12.42 |
| Revenue Growth | ★ 10.20 | N/A |
| 52 Week Low | $4.31 | $4.40 |
| 52 Week High | $9.56 | $6.95 |
| Indicator | DERM | TPVG |
|---|---|---|
| Relative Strength Index (RSI) | 61.47 | 61.89 |
| Support Level | $7.39 | $5.07 |
| Resistance Level | $8.29 | $5.39 |
| Average True Range (ATR) | 0.44 | 0.11 |
| MACD | 0.09 | -0.01 |
| Stochastic Oscillator | 68.27 | 40.35 |
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
TriplePoint Venture Growth BDC Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize its total return to stockholders in the form of current income and, to a lesser extent, capital appreciation. The fund focuses on companies operating in the fields of biofuels, business applications software, wireless communications equipment, e-commerce, clothing and accessories, conferencing equipment and services, personal goods, financial institutions and services, entertainment, mixed retailing, and healthcare services. Geographically, all the firm's operations are located across the United States.